ABEO | Abeona TherapeuticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$4.25
$0.00 (0.00%)

Abeona Therapeutics (ABEO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.

The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $4.25 vs 50 $5.17 / 200 $5.48
Projection
No cross projected
Test
No active test
Last cross
Death cross 21 Oct 2026 ยท projected 30 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $4.35 vs 50 $5.40 / 200 $5.09
Projection
Death cross projected in 15 bars
Test
No active test
Last cross
Golden cross week of 28 Jul 2025 ยท projected 14 bars out ยท tested 1 bar

4-hour as of 3 Nov 16:00 ET

Price
below both $4.25 vs 50 $4.66 / 200 $5.76
Projection
No cross projected
Test
No active test
Last cross
Death cross 16 Sep 2026 bar 1 ยท projected 18 bars out ยท tested 1 bar

Cross history

27
crosses on record since 2017
14 golden13 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
21 Oct 2026Death steepdaily30 bars outNot tested
16 Sep 2026Death4-hour18 bars out1 bar cross test
4 Jun 2026Golden moderatedaily28 bars out6 bar cross test
1 May 2026Golden4-hour28 bars outNot tested
20 Mar 2026Death4-hour24 bars outNot tested

About ABEO

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$6.4M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.